escmid.bsky.social
Championing medical progress in infection for a healthier tomorrow. ESCMID is committed to advancing the fields of clinical microbiology and infectious diseases.
👤 Joined on 04 September 2024
Followers
Following
Total Posts
@escmid.bsky.socialOriginal article evaluating whether early antifungal prophylaxis reduces the incidence of influenza-associated pulmonary aspergillosis (IAPA) in critically ill adults with influenza: www.clinicalmicrobiologyandinfection.org/article/S119... #IDSky #clinmicro #MedSky
Show Post📣 In the October 2026 issue: The @escmid.bsky.social framework for reaching consensus in clinical guidelines www.clinicalmicrobiologyandinfection.org/article/S119... #IDSky #MicroSky
Show Post🎙️ Just published 'Does oseltamivir harm critically ill patients? The REMAP-CAP results' Hosted by Erin McCreary, PharmD & Josh Davis with invited guests Steve Webb & Steven Tong 🌟 Listen on #Communicable https://ow.ly/pJAO50ZOfK8 or on #Breakpoints https://ow.ly/p8Ti50ZOfK9 #IDSky #ViroSky #flu
Show Post📣 New #Communicable / #Breakpoints drops Mon 21 Sep! Erin McCreary, PharmD & Josh Davis are joined by Steve Webb & Steven Tong to discuss REMAP-CAP results suggesting that oseltamivir may harm critically ill patients, while also highlighting the importance and impact of RCTs. #IDSky #ViroSky #flu
Show PostIn honor of #PeerReviewWeek we would like to thank our peer reviewers for their important and insightful contributions to CMI. We deeply value the time, effort and expertise that goes into writing each peer-review.
Show Post